
    
      The investigators enrolled patients on maintenance hemodialysis and randomized them to two
      groups. One group will receive lanthanum carbonate and another group will receive calcium
      carbonate. The investigators will compare serum FGF23 levels between two groups after they
      receive above medication for 6 months.
    
  